Source: PaxForex Premium Analytics Portal, Technical Insight

Pfizer and BioNTech share positive early data on the leading mRNA candidate vaccine BNT162b2 against COVID-19. In a Phase 1 study in the U.S., 7 days after a second 30 µg dose, BNT162b2 induced SARS-CoV-2 neutralizing Mean Geometric Titers (GMTs) among young people (18-55 years) at 3, 8 times the GMT panel of 38 sera recovery patients with SARS-CoV-2 and in elderly people (65-85 years old) the candidate vaccine caused a GMT neutralizing 1.6 times the GMT panel of the same panel, demonstrating strong immunogenicity in young and elderly people.

Pfizer, H4

Pivot: 38.65

Analysis:

Provided that the asset is traded above 37.54, follow the recommendations below:

• Time frame: H4
• Recommendation: long position
• Entry point: 38.65
• Take Profit 1:  39.48
• Take Profit 2: 40.91

Alternative scenario: 

In case of breakdown of the level 37.54, follow the recommendations below:

• Time frame: H4
• Recommendation: short position
• Entry point: 37.54
• Take Profit 1: 36.48
• Take Profit 2: 34.55

Comment:

RSI shows an uptrend during the day.

Key levels:

Pfizer, D1

Pivot: 39.50

Analysis:

While the asset is traded above 36.91, follow the recommendations below:

• Time frame: D1
• Recommendation: long position
• Entry point: 39.50
• Take Profit 1: 42.25
• Take Profit 2: 44.51

Alternative scenario:

If the level 36.91 is broken-down, follow the recommendations below.

• Time frame: D1
• Recommendation: short position
• Entry point: 36.91
• Take Profit 1: 32.61
• Take Profit 2: 31.47

Comment:

RSI shows a medium-term uptrend.

Key levels:

We also advise you to pay attention to Apple for intraday trading:

Pivot: 471.86

Analysis:

While the asset is traded above 465.40, follow the recommendations below:

• Time frame: H4
• Recommendation: long position
• Entry point: 471.86
• Take Profit 1: 479.00
• Take Profit 2: 482.40

Alternative scenario:

If the level 465.40 is broken-down, follow the recommendations below.

• Time frame: H4
• Recommendation: short position
• Entry point: 465.40
• Take Profit 1: 459.60
• Take Profit 2: 456.20